We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

406 hedge funds and large institutions have $17.3B invested in Alexion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 406 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $149M | Put options by funds: $97.1M

Holders
406
Holders Change
+406
Holders Change %
–
% of All Funds
13.25%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.2%
New
406
Increased
–
Reduced
–
Closed
–
Calls
$149M
Puts
$97.1M
Net Calls
+$51.9M
Net Calls Change
+$51.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TRSOTSOK
201
Teachers Retirement System of the State of Kentucky
Kentucky
$3.27M +$3.41M +35,400 New
URS
202
Utah Retirement Systems
Utah
$3.23M +$3.38M +35,042 New
BF
203
BOK Financial
Oklahoma
$3.14M +$3.28M +34,067 New
Macquarie Group
204
Macquarie Group
Australia
$3.06M +$3.2M +33,230 New
RFC
205
Regions Financial Corp
Alabama
$3.04M +$3.17M +32,927 New
NCGI
206
Next Century Growth Investors
Minnesota
$2.96M +$3.09M +32,051 New
CAM
207
Capstone Asset Management
Texas
$2.87M +$2.99M +31,065 New
NMERB
208
New Mexico Educational Retirement Board
New Mexico
$2.86M +$2.99M +31,000 New
GLAM
209
Gardner Lewis Asset Management
Pennsylvania
$2.84M +$2.96M +30,755 New
AAMU
210
Amundi Asset Management US
Massachusetts
$2.81M +$2.94M +30,500 New
Two Sigma Advisers
211
Two Sigma Advisers
New York
$2.66M +$2.78M +28,831 New
DCM
212
Driehaus Capital Management
Illinois
$2.45M +$2.56M +26,576 New
Los Angeles Capital Management
213
Los Angeles Capital Management
California
$2.41M +$2.52M +26,103 New
LIM
214
Leavell Investment Management
Alabama
$2.38M +$2.48M +25,765 New
BNP Paribas Asset Management
215
BNP Paribas Asset Management
France
$2.33M +$2.44M +25,307 New
FWIA
216
Fort Washington Investment Advisors
Ohio
$2.32M +$2.43M +25,175 New
LOAMU
217
Lombard Odier Asset Management (USA)
New York
$2.31M +$2.41M +25,000 New
BOTW
218
Bank of the West
California
$2.29M +$2.4M +24,882 New
SMDAM
219
Sumitomo Mitsui DS Asset Management
Japan
$2.27M +$2.38M +24,649 New
AAM
220
Advisors Asset Management
Colorado
$2.21M +$2.31M +24,000 New
Janus Henderson Group
221
Janus Henderson Group
United Kingdom
$2.21M +$2.22M +23,065 New
BSA
222
Braun Stacey Associates
New York
$2.14M +$2.23M +23,170 New
AG
223
Aperio Group
California
$2.13M +$2.22M +23,056 New
Nomura Asset Management
224
Nomura Asset Management
Japan
$2.09M +$2.19M +22,690 New
AQR Capital Management
225
AQR Capital Management
Connecticut
$2.08M +$2.18M +22,575 New
7 8
9
10 11

ALXN Hedge Fund Activity: Q2 2013 in Review

406 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q2 2013, worth a combined $17.3B.

Buyers outnumbered sellers: 406 funds opened new ALXN positions and 0 closed out — a net gain of 406 holders — while 0 added to existing stakes and 0 trimmed.

  • 406 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.3B of Alexion Pharmaceuticals stock for Q2 2013.
  • 406 funds opened new Alexion Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +406 holders.

Based on aggregated 13F filings for Q2 2013.